GO:0090205 positive regulation of cholesterol metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090205 describes any process that increases the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, the principal sterol of vertebrates and precursor of bile acids and steroid hormones.
• Positive regulation of cholesterol metabolic process is executed through transcriptional control of sterol biosynthesis genes, post-translational modification of rate-limiting enzymes, and inter-organ sterol transport.
• Key regulators include SCAP, SQLE, SCARB1, and ZDHHC3, whose activities are modulated by nutrient sensing, S-acylation, and epigenetic modifications.
• Dysregulation of this process contributes to hepatocellular carcinoma immune escape, clear cell renal cell carcinoma progression, and impaired CD8+ T cell antitumor immunity.
• Dietary lipids, including trans fatty acids, and intestinal cholesterol transport directly influence systemic cholesterol metabolic flux and immune responses.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for dissecting causal roles of individual genes within this GO term.
Description
Cholesterol is an essential sterol that serves as a structural component of cell membranes and as the precursor for bile acids, steroid hormones, and vitamin D. The Gene Ontology term GO:0090205, positive regulation of cholesterol metabolic process, encompasses any process that increases the rate, frequency, or extent of cholesterol metabolism. This term is critical for researchers because cholesterol homeostasis is tightly linked to metabolic disease, cancer immunity, and neurological function. Understanding the positive regulators of cholesterol metabolism provides mechanistic insight into how cells adapt to nutrient availability and how tumors reprogram lipid pathways to evade immune surveillance. The process is not a single reaction but a coordinated network involving transcriptional regulators such as SREBP and SCAP, enzymes such as squalene epoxidase (SQLE), and transport proteins such as SCARB1. Recent studies have demonstrated that post-translational modifications, including S-acylation and delactylation, can acutely control the activity and stability of these regulators, thereby tuning cholesterol synthesis and uptake. Moreover, inter-organ communication, particularly between the intestine and immune cells, highlights the systemic nature of cholesterol metabolic regulation. For biomedical researchers, GO:0090205 offers a framework to interrogate how genetic and pharmacological perturbations alter cholesterol flux and to identify therapeutic targets in cancer, metabolic syndrome, and neurodegeneration.
positive regulation of cholesterol metabolic process At A Glance
| GO ID | GO:0090205 |
|---|---|
| GO term | positive regulation of cholesterol metabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Upregulation of cholesterol synthesis, transport, and utilization pathways |
| Definition source | QuickGO |
| Related processes | Sterol biosynthesis, bile acid synthesis, steroid hormone production |
| Key regulators | SCAP, SQLE, SCARB1, ZDHHC3, SREBP |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration |
What Is GO:0090205?
GO:0090205 is defined by QuickGO as any process that increases the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. In practical terms, this ontology term captures all molecular events that upregulate the synthesis, modification, transport, or utilization of cholesterol, whether through increased enzyme activity, enhanced gene expression, or altered protein stability.
Why Is positive regulation of cholesterol metabolic process Important in Cell Biology?
Positive regulation of cholesterol metabolic process is fundamentally important because cholesterol is indispensable for membrane integrity, cell signaling, and the production of bioactive steroids and bile acids. When this process is aberrantly activated, it can drive tumor immune escape, as shown in hepatocellular carcinoma where SCAP S-acylation promotes cholesterol biosynthesis and suppresses antitumor immunity. In clear cell renal cell carcinoma, circABCA1 reprograms cholesterol metabolism to facilitate M2 macrophage polarization, linking this GO term to tumor microenvironment remodeling. Conversely, adequate cholesterol biosynthesis is required for CD8+ T cell antitumor function, and its inhibition by tRNA m1A modification impairs immune responses. In the brain, lipids and cholesterol metabolism influence cognition, and dysregulation is associated with Alzheimer's disease. Dietary factors such as trans fatty acids also modulate cholesterol metabolism, underscoring the environmental sensitivity of this process. Therefore, understanding GO:0090205 is essential for developing therapeutic strategies that target cholesterol metabolic vulnerabilities in cancer and metabolic disease.
• Cholesterol is the precursor of bile acids and steroid hormones, making its positive regulation central to endocrine and digestive physiology.
• SCAP S-acylation by ZDHHC3 promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma.
• CircABCA1 stabilizes SCARB1 mRNA to reprogram cholesterol metabolism and promote M2 macrophage polarization in ccRCC.
• tRNA m1A modification regulates cholesterol biosynthesis to support CD8+ T cell antitumor immunity.
• PD-L1 delactylation enhances SQLE transcription activity and accelerates liver cancer growth.
• Glutamine sensing licenses cholesterol synthesis, linking amino acid metabolism to sterol production.
• T cell cholesterol transport connects intestinal immune responses to dietary lipid absorption.
• Trans fatty acids alter cholesterol metabolism and are associated with cardiovascular risk.
• Lipids and cognition are linked, with cholesterol metabolism implicated in Alzheimer's disease.
• CRISPR-based models enable causal testing of genes that positively regulate cholesterol metabolism.
What Happens During positive regulation of cholesterol metabolic process?
Transcriptional activation of sterol biosynthesis genes
In simple terms: The cell senses low cholesterol and turns on the genes needed to make more.
When cellular cholesterol levels decline, the SREBP-SCAP complex translocates from the endoplasmic reticulum to the Golgi, where SREBP is cleaved and released to activate transcription of genes encoding HMG-CoA reductase, squalene epoxidase (SQLE), and other enzymes in the mevalonate pathway. This transcriptional program increases the capacity for de novo cholesterol synthesis. In cancer cells, this pathway can be co-opted; for example, PD-L1 delactylation promotes nuclear translocation and elevates SQLE transcription activity, accelerating liver cancer growth.
Post-translational modification of cholesterol regulatory proteins
In simple terms: Chemical tags added to proteins can switch cholesterol production on or off.
S-acylation of SCAP by ZDHHC3 enhances its stability and promotes cholesterol biosynthesis, leading to tumor immune escape in hepatocellular carcinoma. Similarly, delactylation of PD-L1 alters its nuclear translocation and transcriptional activity toward SQLE. These modifications provide rapid, reversible control of cholesterol metabolism independent of transcription.
Cholesterol uptake and transport
In simple terms: Cells can also increase cholesterol by taking it up from outside.
SCARB1 (SR-BI) mediates selective uptake of HDL cholesterol. In clear cell renal cell carcinoma, circABCA1 promotes SCARB1 mRNA stabilization via IGF2BP3, enhancing cholesterol uptake and reprogramming metabolism to facilitate M2 macrophage polarization. T cell cholesterol transport is also linked to intestinal immune responses and dietary lipid absorption, indicating systemic coordination.
Nutrient sensing and metabolic licensing
In simple terms: The cell checks if it has enough building blocks before making cholesterol.
Glutamine availability licenses cholesterol synthesis, coupling amino acid sensing to sterol production. This ensures that cholesterol biosynthesis is not initiated when energy or substrate supplies are insufficient. Trans fatty acids can also modulate these pathways, affecting membrane composition and metabolic flux.
Immune-metabolic crosstalk
In simple terms: Cholesterol levels affect how immune cells fight tumors.
Cholesterol biosynthesis is required for CD8+ T cell antitumor immunity, and its regulation by tRNA m1A modification influences immune function. In contrast, tumor cells can upregulate cholesterol metabolism to evade immune attack, as seen with SCAP S-acylation and circABCA1-mediated reprogramming. This crosstalk highlights the importance of context-dependent regulation.
Key Genes Involved in GO:0090205 positive regulation of cholesterol metabolic process
The following genes and proteins are experimentally validated regulators or effectors of positive regulation of cholesterol metabolic process, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCAP | SREBP cleavage-activating protein; escorts SREBP to Golgi for activation | S-acylation by ZDHHC3 promotes cholesterol biosynthesis and immune escape |
| SQLE | Squalene epoxidase; rate-limiting enzyme in cholesterol synthesis | PD-L1 delactylation elevates SQLE transcription in liver cancer |
| SCARB1 | Scavenger receptor class B member 1; mediates HDL cholesterol uptake | Stabilized by circABCA1/IGF2BP3 in ccRCC |
| ZDHHC3 | Palmitoyltransferase; S-acylates SCAP | Promotes cholesterol biosynthesis and tumor immune escape |
| PD-L1 | Immune checkpoint protein; nuclear translocation regulates SQLE | Delactylation promotes liver cancer growth |
| IGF2BP3 | RNA-binding protein; stabilizes SCARB1 mRNA | Facilitates M2 macrophage polarization in ccRCC |
| ABCA1 | Cholesterol efflux transporter; circABCA1 derived from its locus | CircABCA1 reprograms cholesterol metabolism in ccRCC |
| SREBP | Sterol regulatory element-binding protein; master transcription factor | Central to transcriptional activation of cholesterol synthesis |
| HMGCR | HMG-CoA reductase; rate-limiting enzyme of mevalonate pathway | Target of SREBP transcriptional program |
| CD8+ T cells | Immune effector cells; require cholesterol for antitumor function | tRNA m1A modification regulates cholesterol biosynthesis |
| Intestinal T cells | Tissue-resident immune cells; link lipid absorption to immunity | Cholesterol transport connects intestinal immune responses |
| Trans fatty acids | Dietary lipids; modulate cholesterol metabolism | Mechanisms of action reviewed |
| ApoE | Apolipoprotein E; cholesterol transport in brain | Lipids and cognition in Alzheimer's disease |
| CYP7A1 | Cholesterol 7-alpha-hydroxylase; bile acid synthesis | Cholesterol is precursor of bile acids |
| CYP11A1 | Cholesterol side-chain cleavage enzyme; steroidogenesis | Cholesterol is precursor of steroid hormones |
| LDLR | Low-density lipoprotein receptor; cholesterol uptake | Regulated by SREBP pathway |
| NPC1L1 | Intestinal cholesterol absorption | Dietary lipid absorption linked to immunity |
| mTOR | Nutrient sensor; may influence cholesterol synthesis | Glutamine sensing licenses cholesterol synthesis |
How Is positive regulation of cholesterol metabolic process Regulated?
Positive regulation of cholesterol metabolic process is controlled at multiple levels. Transcriptional regulation via SREBP-SCAP is the primary mechanism, responding to sterol depletion. Post-translational modifications such as S-acylation of SCAP by ZDHHC3 enhance cholesterol biosynthesis, while delactylation of PD-L1 alters SQLE transcription. Nutrient availability, particularly glutamine, licenses cholesterol synthesis through mTOR-related signaling. Additionally, tRNA m1A modification regulates cholesterol biosynthesis in CD8+ T cells, linking epitranscriptomic control to metabolic regulation. Dietary factors such as trans fatty acids can also modulate cholesterol metabolism.
positive regulation of cholesterol metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCAP | Hepatocellular carcinoma immune escape | KO and point-mutation in HCC cell lines; syngeneic mouse models |
| SQLE | Liver cancer growth | Overexpression and knockout in hepatoma cells; xenograft |
| SCARB1 | Clear cell renal cell carcinoma | Knockout and knock-in in ccRCC cells; macrophage co-culture |
| ZDHHC3 | Tumor immune escape | KO in cancer cells; T cell cytotoxicity assays |
| PD-L1 | Liver cancer | Point mutation of lactylation sites; knock-in models |
Cancer and tumor immune escape
Upregulation of cholesterol metabolism supports tumor growth and immune evasion. In hepatocellular carcinoma, ZDHHC3-mediated S-acylation of SCAP promotes cholesterol biosynthesis and tumor immune escape. In liver cancer, PD-L1 delactylation enhances SQLE transcription activity, accelerating tumor growth. In clear cell renal cell carcinoma, circABCA1 reprograms cholesterol metabolism and facilitates M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA. These findings position positive regulation of cholesterol metabolic process as a therapeutic target in oncology.
Antitumor immunity and T cell function
Cholesterol biosynthesis is required for CD8+ T cell antitumor immunity. tRNA m1A modification regulates this process, and its perturbation impairs immune responses. T cell cholesterol transport also links intestinal immune responses to dietary lipid absorption, suggesting that systemic lipid metabolism influences immune surveillance.
Neurodegeneration and cognition
Lipids and cognition are closely linked, and cholesterol metabolism in the brain is essential for neuronal function. Dysregulation of cholesterol metabolic processes has been implicated in Alzheimer's disease and other neurodegenerative conditions. The blood-brain barrier and ApoE-mediated transport are key components of this relationship.
Metabolic and cardiovascular disorders
Trans fatty acids modulate cholesterol metabolism and are associated with cardiovascular risk. Glutamine sensing and nutrient availability also influence cholesterol synthesis, linking metabolic syndrome to sterol regulation. Understanding positive regulation of cholesterol metabolic process may inform dietary and pharmacological interventions.
From positive regulation of cholesterol metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SCAP S-acylation required for cholesterol biosynthesis? | SCAP point-mutation (S-acylation site) knock-in cells |
| Does SQLE overexpression drive liver cancer growth? | SQLE overexpression and knockout in hepatoma cell lines |
| How does circABCA1 affect SCARB1 mRNA stability? | CircABCA1 knockout and overexpression in ccRCC cells |
| Does ZDHHC3 knockout impair tumor immune escape? | ZDHHC3 knockout in cancer cells co-cultured with T cells |
| What is the role of PD-L1 delactylation in SQLE transcription? | PD-L1 point-mutation (lactylation site) knock-in |
| Can cholesterol biosynthesis be monitored in live cells? | Tagged knock-in of SQLE or SCAP with fluorescent reporters |
How to Study the positive regulation of cholesterol metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes in cholesterol genes | SREBP target gene profiling |
| Proteomics | Protein abundance and modifications | SCAP S-acylation, PD-L1 lactylation |
| Lipidomics | Cholesterol and intermediates | Functional validation of metabolic flux |
| Cholesterol assay | Total and free cholesterol | Quantification in cells and tissues |
| Fluorescence microscopy | Subcellular localization | SCAP trafficking, SQLE nuclear translocation |
| Co-culture cytotoxicity | T cell-mediated killing | Tumor immune escape |
| CRISPR screening | Gene essentiality in cholesterol metabolism | Identify novel regulators |
| Bioinformatics | Pathway enrichment and networks | Integrate multi-omics data |
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify global changes in cholesterol metabolic genes upon perturbation of regulators such as SCAP or SQLE. These methods reveal SREBP target gene signatures and compensatory pathways.
Lipidomics and cholesterol quantification
Mass spectrometry-based lipidomics and enzymatic cholesterol assays measure total and free cholesterol, cholesteryl esters, and intermediates in the mevalonate pathway. Such methods are essential to confirm functional changes in cholesterol metabolism.
Imaging and subcellular localization
Fluorescence microscopy with tagged SCAP, SQLE, or SCARB1 can track translocation and co-localization with organelles. This is particularly useful for studying SREBP-SCAP trafficking and nuclear translocation of PD-L1.
Immune cell functional assays
Co-culture of tumor cells with T cells and cytotoxicity assays can assess immune escape driven by cholesterol metabolism. These assays are critical for validating targets such as SCAP and ZDHHC3.
How CRISPR Can Be Used to Study GO:0090205 positive regulation of cholesterol metabolic process
Knockout
CRISPR knockout of genes such as SCAP, SQLE, or ZDHHC3 can abolish positive regulation of cholesterol metabolic process, leading to reduced cholesterol synthesis and impaired tumor growth. Knockout models are essential to establish causality.
Point Mutation
Point mutations can be introduced to disrupt specific post-translational modification sites, such as S-acylation sites on SCAP or lactylation sites on PD-L1, to test their role in cholesterol metabolism.
Knock-in
Knock-in of tagged versions of SCAP, SQLE, or SCARB1 allows live-cell imaging and proteomic analysis of cholesterol regulatory complexes.
Overexpression
Overexpression of circABCA1 or SQLE can drive cholesterol metabolic reprogramming and immune escape, providing gain-of-function models.
How EDITGENE Supports positive regulation of cholesterol metabolic process Research
Researchers studying positive regulation of cholesterol metabolic process-related genes often need to determine whether a candidate gene is causally involved in cholesterol synthesis, transport, or immune modulation. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cholesterol metabolic process research.
Frequently Asked Questions About positive regulation of cholesterol metabolic process
What is GO:0090205?
GO:0090205 is the Gene Ontology term for positive regulation of cholesterol metabolic process, defined as any process that increases the rate, frequency, or extent of cholesterol metabolism.
What genes are involved in positive regulation of cholesterol metabolic process?
Key genes include SCAP, SQLE, SCARB1, ZDHHC3, PD-L1, and IGF2BP3, as shown in cancer and immune studies.
How is cholesterol metabolism positively regulated?
It is regulated transcriptionally by SREBP-SCAP, post-translationally by S-acylation and delactylation, and through nutrient sensing such as glutamine availability.
What diseases are linked to positive regulation of cholesterol metabolic process?
It is linked to hepatocellular carcinoma, clear cell renal cell carcinoma, impaired CD8+ T cell immunity, and Alzheimer's disease.
What is the role of SCAP in cholesterol metabolism?
SCAP escorts SREBP to the Golgi for activation; its S-acylation by ZDHHC3 promotes cholesterol biosynthesis and tumor immune escape.
How does SQLE contribute to liver cancer?
PD-L1 delactylation promotes nuclear translocation and elevates SQLE transcription activity, accelerating liver cancer growth.
What is the function of SCARB1 in ccRCC?
SCARB1 mediates HDL cholesterol uptake and is stabilized by circABCA1/IGF2BP3, reprogramming cholesterol metabolism in ccRCC.
How do T cells regulate cholesterol metabolism?
tRNA m1A modification regulates cholesterol biosynthesis to support CD8+ T cell antitumor immunity.
Can CRISPR be used to study cholesterol metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect cholesterol regulatory genes.
What methods measure cholesterol metabolic flux?
Lipidomics, cholesterol assays, RNA-seq, proteomics, and imaging are commonly used to measure cholesterol metabolic changes.
Conclusion
GO:0090205, positive regulation of cholesterol metabolic process, is a central biological process that controls cholesterol synthesis, uptake, and utilization. Its dysregulation contributes to cancer progression, immune evasion, and neurodegeneration. The integration of CRISPR-based models with multi-omics and functional assays will continue to uncover new regulators and therapeutic opportunities. EDITGENE offers end-to-end services to support these investigations.
References
- 1. Oteng AB et al.. 2020. Mechanisms of Action of trans Fatty Acids.. Adv Nutr 11(3):697-708 PMID: 31782488
- 2. Wang X et al.. 2025. PD-L1 delactylation-promoted nuclear translocation accelerates liver cancer growth through elevating SQLE transcription activity.. Cancer Lett 630:217901 PMID: 40614853
- 3. Gao Y et al.. 2025. T cell cholesterol transport links intestinal immune responses to dietary lipid absorption.. Science 390(6769):eadt4169 PMID: 41066556
- 4. Garcia BM et al.. 2024. Glutamine sensing licenses cholesterol synthesis.. EMBO J 43(23):5837-5856 PMID: 39433901
- 5. Wu M et al.. 2024. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma.. Cell Rep 43(11):114962 PMID: 39522165
- 6. Ning H et al.. 2025. CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA.. Mol Cancer 24(1):199 PMID: 40684174
- 7. Miao S et al.. 2025. tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells.. J Exp Med 222(3) PMID: 39873720
- 8. Morley JE et al.. 2010. Lipids and cognition.. J Alzheimers Dis 20(3):737-47 PMID: 20413879
